Showing results (51-60 of 2,355) with videos related to

Sort By:
Pageof 236
Clinical Neuropharmacology|May 14, 1998
Clozapine for the treatment of agitated-depressed patients with cognitive impairment: a report of three casesN Nacasch, O T Dolberg, S Hirschmann, et al.
Clinical Neuropharmacology|October 1, 1989
The influence of levodopa in the pharmacokinetics of bromocriptine in Parkinson's diseaseJ M Rabey, Z Oberman, M Scharf, et al.
Clinical Neuropharmacology|August 3, 2016
Encephalitis With Antibodies to GluN2B During Administration of ClozapineJunji Gon, Yasushi Takehisa, Yuji Yada, et al.
Clinical Neuropharmacology|July 14, 2015
Tolerability and Safety of Combined Glatiramer Acetate and N-Acetylcysteine in Relapsing-Remitting Multiple SclerosisHyman M Schipper, Douglas Arnold, Francois GrandʼMaison, et al.
Clinical Neuropharmacology|March 30, 2018
Treatment of Depression With Duloxetine in Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like EpisodesBrittany Cozart, Jesus Diaz Vera, James D Denham, et al.
Clinical Neuropharmacology|January 1, 1986
Plasma beta-endorphin and beta-lipotropin in patients with Parkinson's diseaseM Franceschi, R Cecchetto, A E Panerai, et al.
Clinical Neuropharmacology|February 24, 2018
Acute Onset of Abdominal Muscle Dyskinesia ('Belly Dancer Syndrome') From Quetiapine Exposure: A Case ReportJia-Yin Yeh, Kun-Yu Tu, Ping-Tao Tseng, et al.
Clinical Neuropharmacology|February 24, 2018
Dextromethorphan/Quinidine in Migraine Prophylaxis: An Open-label Observational Clinical StudyRegina R Berkovich, Alexey Y Sokolov, Daniel M Togasaki, et al.
Clinical Neuropharmacology|February 13, 2018
A Well-Tolerated and Effective Antiepileptic Drug for Patients With Myasthenia Gravis at Last?José Manuel Sánchez-Villalobos, Irene Villegas-Martínez, José Antonio Pérez-Vicente
Pageof 236